Nivolumab? Expires 2023/2024. So expect relatlimab to be combined with their next generation PD-1 (or other target IT drug) sometime in the next 1-2 years.
This site uses cookies to help personalize content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies and terms of service.